SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : Nuvo Research Inc
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Cal Gary who wrote (4988)8/2/2000 2:48:29 PM
From: Montana Wildhack  Read Replies (1) of 14101
 
CG,

"Wolf, the pharmacy (or rather should I say the pharmacist) is NOT the primary driver for prescription sales. This
belongs to the physician. That's why almost all marketing efforts go towards trying to persuade the physician to use
the product."

I agree.

The comment about $45 to the pharmacies is to quantify
revenue potential.

As I've posted weeks back, the doctors will go to Pennsaid
as the first alternative because it is proven safe and
effective.

I've also posted that Dimethaid is making 15ml and 60ml
size Pennsaid. The 15ml is for samples for use just as
you say.

Wolf
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News